|Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors|
AM Farrar, KN Segovia, PA Randall, EJ Nunes, LE Collins, CM Stopper, ...
Neuroscience 166 (4), 1056-1067, 2010
|The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit …|
AM Mott, EJ Nunes, LE Collins, RG Port, KS Sink, J Hockemeyer, ...
Psychopharmacology 204 (1), 103, 2009
|Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism|
JD Salamone, AM Farrar, L Font, V Patel, DE Schlar, EJ Nunes, ...
Behavioural brain research 201 (1), 216-222, 2009
|Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142|
KS Sink, KN Segovia, J Sink, PA Randall, LE Collins, M Correa, ...
European Neuropsychopharmacology 20 (2), 112-122, 2010
|The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats|
KS Sink, KN Segovia, LE Collins, EJ Markus, VK Vemuri, A Makriyannis, ...
Pharmacology Biochemistry and Behavior 95 (4), 479-484, 2010
|Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity|
LE Collins, DJ Galtieri, P Collins, SK Jones, RG Port, NE Paul, ...
Behavioural brain research 211 (2), 148-155, 2010
|Soluble amyloid beta levels are elevated in the white matter of Alzheimer’s patients, independent of cortical plaque severity|
LE Collins-Praino, YI Francis, EY Griffith, AF Wiegman, J Urbach, ...
Acta neuropathologica communications 2 (1), 1-10, 2014
|APOE ε4 and risk for Alzheimer's disease: Do regionally distributed white matter hyperintensities play a role?|
AM Brickman, N Schupf, JJ Manly, Y Stern, JA Luchsinger, ...
Alzheimer's & Dementia 10 (6), 619-629, 2014
|Role of dopamine–adenosine interactions in the brain circuitry regulating effort-related decision making: insights into pathological aspects of motivation|
JD Salamone, M Correa, AM Farrar, EJ Nunes, LE Collins
Future Neurology 5 (3), 377-392, 2010
|Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?|
LE Collins-Praino, F Corrigan
Brain, behavior, and immunity 60, 369-382, 2017
|The novel adenosine A2A antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions|
JL Santerre, EJ Nunes, R Kovner, CE Leser, PA Randall, ...
Pharmacology Biochemistry and Behavior 102 (4), 477-487, 2012
|Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor|
LE Collins-Praino, NE Paul, K Rychalsky, JR Hinman, JJ Chrobak, ...
Frontiers in Systems Neuroscience 5, 49, 2011
|Evolution and significance of the triple risk model in sudden infant death syndrome|
J Spinelli, L Collins‐Praino, C Van Den Heuvel, RW Byard
Journal of paediatrics and child health 53 (2), 112-115, 2017
|The effect of an acute systemic inflammatory insult on the chronic effects of a single mild traumatic brain injury|
LE Collins-Praino, A Arulsamy, V Katharesan, F Corrigan
Behavioural brain research 336, 22-31, 2018
|Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor|
S Podurgiel, LE Collins-Praino, S Yohn, PA Randall, A Roach, ...
Pharmacology Biochemistry and Behavior 105, 105-111, 2013
|The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade|
LE Collins, TN Sager, AG Sams, A Pennarola, RG Port, M Shahriari, ...
Pharmacology Biochemistry and Behavior 100 (3), 498-505, 2012
|Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats|
KS Sink, KN Segovia, EJ Nunes, LE Collins, VK Vemuri, G Thakur, ...
Psychopharmacology 206 (2), 223-232, 2009
|Oral tremor induced by galantamine in rats: A model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease|
LE Collins, NE Paul, SF Abbas, CE Leser, SJ Podurgiel, DJ Galtieri, ...
Pharmacology Biochemistry and Behavior 99 (3), 414-422, 2011
|Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation|
F Corrigan, A Arulsamy, LE Collins-Praino, JL Holmes, R Vink
Brain, Behavior, and Immunity 64, 124-139, 2017
|Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX|
LE Collins, DJ Galtieri, LT Brennum, TN Sager, J Hockemeyer, CE Müller, ...
Pharmacology Biochemistry and Behavior 94 (4), 561-569, 2010